Genetically predicted APOC3 lowering was associated with a lower risk of CAD (odds ratio [OR] per 1 SD [standard deviation] lower APOC3 plasma levels = 0.83, 95% CI = 0.75–0.92, P = 4.6e-04) (Figure 2). Here, APOC3 is linked to coronary artery disorder.